Neuroethics Program, Cleveland Clinic.
Neurological Institute, Cleveland Clinic.
AJOB Neurosci. 2022 Oct-Dec;13(4):215-226. doi: 10.1080/21507740.2021.1938293. Epub 2021 Jul 13.
As clinical trials end, little is understood about how participants exiting from clinical trials approach decisions related to the removal or post-trial use of investigational brain implants, such as deep brain stimulation (DBS) devices. This empirical bioethics study examines how research participants experience the process of exit from research at the end of clinical trials of implanted neural devices. Using a modified grounded theory study design, we conducted semi-structured, in-depth interviews with 16 former research participants from clinical trials of DBS and responsive neurostimulation (RNS). Open-ended questions elicited motivations for joining the trial, understanding of study procedures at the time of initial informed consent, the process of exiting from research, and decisions about device removal or post-trial device use. Thematic analysis identified categories related to: limited preparedness for the end of research participation, straightforwardness of decisions to explant or keep the device, reconciling with the end of research participation, reconciling post-trial expectations, and achieving a sense of closure after exit from research. A preliminary theoretical model describes contextual factors influencing the process and experience of exit from research. Experiences of clinical trial participants should guide research practices to enhance the ethical design and conduct of clinical trials in DBS and other brain devices.
当临床试验结束时,人们对于参与者在退出临床试验后如何做出与研究相关的决定知之甚少,例如与研究相关的脑植入物(如深部脑刺激(DBS)设备)的移除或试验后使用。本实证生物伦理学研究探讨了研究参与者在植入神经设备的临床试验结束时如何经历研究退出的过程。我们使用改良的扎根理论研究设计,对 16 名曾参与 DBS 和反应性神经刺激(RNS)临床试验的前研究参与者进行了半结构化、深入的访谈。开放式问题引出了加入试验的动机、在最初知情同意时对研究程序的理解、退出研究的过程以及关于设备移除或试验后设备使用的决定。主题分析确定了与以下内容相关的类别:对研究参与结束的准备有限、决定是否植入或保留设备的简单性、与研究参与结束的和解、与试验后期望的和解以及退出研究后的结束感。一个初步的理论模型描述了影响退出研究过程和体验的情境因素。临床试验参与者的经验应指导研究实践,以加强 DBS 和其他脑设备临床试验的伦理设计和实施。